Greg Boustead
Community Manager
Spectrum
From this contributor
Takeaways from IMFAR 2015
Scientists and the autism community come together for the 2015 International Meeting for Autism Research in Salt Lake City, Utah.
Reactions from IMFAR 2015
Tune in for daily updates and reactions from attendees at the 2015 International Meeting for Autism Research in Salt Lake City, Utah.
Dispatches from IMFAR 2015
These short reports from our journalists give you the inside scoop on developments at the 2015 International Meeting for Autism Research.
Dispatches from IMFAR 2015
Summer Institute for Autism Research: An online series
The International Society for Autism Research and SFARI.org together present a series of six weekly interactive presentations, intended for early-career investigators interested in autism research.
Summer Institute for Autism Research: An online series
Live Twitter chat from IMFAR 2015
On Friday, 15 May SFARI.org hosted a Twitter Q&A chat live from the floors of the 2015 International Meeting for Autism Research in Salt Lake City, Utah.
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.